• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死后射血分数轻度降低患者的两年临床结局:来自前瞻性KAMIR-NIH注册研究的见解

Two-year clinical outcome of patients with mildly reduced ejection fraction after acute myocardial infarction: insights from the prospective KAMIR-NIH Registry.

作者信息

Jeon Ho Sung, Lee Jun-Won, Moon Jin Sil, Kang Dae Ryong, Lee Jung-Hee, Youn Young Jin, Ahn Min-Soo, Ahn Sung Gyun, Yoo Byung-Su

机构信息

Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju Severance Christian Hospital, Wonju, Republic of Korea.

Center of Biomedical Data Science, Yonsei University Wonju Severance Christian Hospital, Wonju, Republic of Korea.

出版信息

Front Cardiovasc Med. 2024 Sep 20;11:1458740. doi: 10.3389/fcvm.2024.1458740. eCollection 2024.

DOI:10.3389/fcvm.2024.1458740
PMID:39371398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451438/
Abstract

BACKGROUND

Left ventricular ejection fraction (LVEF) is a crucial prognostic indicator of acute myocardial infarction (AMI). However, there is a lack of studies on the clinical characteristics and prognosis of patients with mildly reduced ejection fraction (EF) after AMI.

METHODS

We categorized 6,553 patients with AMI from the Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) between November 2011 and December 2015 into three groups based on their EF, as assessed by echocardiography during index hospitalization: reduced EF (LVEF ≤40%), mildly reduced EF (LVEF 41%-49%), and preserved EF (LVEF ≥50%). The primary outcome was all-cause death within 2 years. The secondary outcomes included myocardial infarction (MI), revascularization, and patient-oriented composite endpoint (POCE), which was defined as a composite of all-cause death, any MI, or revascularization.

RESULTS

Of the total 6,553 patients, 884 (13.5%) were classified into the reduced EF group, 1,749 (26.7%) into the mildly reduced EF group, and 3,920 (59.8%) into the preserved EF group. Patients with mildly reduced EF exhibited intermediate mortality (reduced EF, 24.7%; mildly reduced EF, 8.3%; preserved EF, 4.6%;  < 0.0001), MI (3.9% vs. 2.7% vs. 2.6%;  < 0.0046), and POCE (33.0% vs. 15.6% vs. 12.4%;  < 0.0001) rates, albeit closer to those of the preserved EF. After adjustment for demographics, risk factors, admission status, and discharge medications, patients with mildly reduced EF showed a lower risk of all-cause death than those with reduced EF (mildly reduced EF group as a reference: HR, 1.74; 95% CI, 1.40-2.18;  < 0.001), but it did not differ significantly from those with preserved EF (HR, 0.94; 95% CI, 0.75-1.18;  = 0.999).

CONCLUSIONS

Over a 2-year follow-up period, patients with AMI and mildly reduced EF demonstrated better prognoses than those with reduced EF, but did not differ significantly from those with preserved EF.

CLINICAL TRIAL REGISTRATION

cris.nih.go.kr, identifier: KCT-0000863.

摘要

背景

左心室射血分数(LVEF)是急性心肌梗死(AMI)的关键预后指标。然而,关于AMI后射血分数(EF)轻度降低患者的临床特征和预后的研究较少。

方法

我们将2011年11月至2015年12月期间来自韩国急性心肌梗死注册研究-国立卫生研究院(KAMIR-NIH)的6553例AMI患者,根据其在首次住院期间经超声心动图评估的EF分为三组:EF降低组(LVEF≤40%)、EF轻度降低组(LVEF 41%-49%)和EF保留组(LVEF≥50%)。主要结局是2年内的全因死亡。次要结局包括心肌梗死(MI)、血运重建和以患者为导向的复合终点(POCE),POCE定义为全因死亡、任何MI或血运重建的复合指标。

结果

在总共6553例患者中,884例(13.5%)被分类为EF降低组,1749例(26.7%)为EF轻度降低组,3920例(59.8%)为EF保留组。EF轻度降低的患者表现出中等的死亡率(EF降低组为24.7%;EF轻度降低组为8.3%;EF保留组为4.6%;P<0.0001)、MI发生率(3.9%对2.7%对2.6%;P<0.0046)和POCE发生率(33.0%对15.6%对12.4%;P<0.0001),尽管更接近EF保留组。在对人口统计学、危险因素、入院状态和出院用药进行调整后,EF轻度降低的患者全因死亡风险低于EF降低的患者(以EF轻度降低组为参照:HR,1.74;95%CI,1.40-2.18;P<0.001),但与EF保留的患者无显著差异(HR,0.94;95%CI,0.75-1.18;P=0.999)。

结论

在2年的随访期内,AMI且EF轻度降低的患者预后优于EF降低的患者,但与EF保留的患者无显著差异。

临床试验注册

cris.nih.go.kr,标识符:KCT-0000863。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/e4a97d550f3a/fcvm-11-1458740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/0cfe67007c3d/fcvm-11-1458740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/c2fa94d513e3/fcvm-11-1458740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/e4a97d550f3a/fcvm-11-1458740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/0cfe67007c3d/fcvm-11-1458740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/c2fa94d513e3/fcvm-11-1458740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e5/11451438/e4a97d550f3a/fcvm-11-1458740-g003.jpg

相似文献

1
Two-year clinical outcome of patients with mildly reduced ejection fraction after acute myocardial infarction: insights from the prospective KAMIR-NIH Registry.急性心肌梗死后射血分数轻度降低患者的两年临床结局:来自前瞻性KAMIR-NIH注册研究的见解
Front Cardiovasc Med. 2024 Sep 20;11:1458740. doi: 10.3389/fcvm.2024.1458740. eCollection 2024.
2
The Role of Oral β-Blockers in Patients With Acute Myocardial Infarction with Preserved or Mildly Reduced Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis.口服β受体阻滞剂在左心室收缩功能正常或轻度降低的急性心肌梗死患者中的作用:一项系统评价和荟萃分析。
Clin Ther. 2025 Sep;47(9):788-797. doi: 10.1016/j.clinthera.2025.06.007. Epub 2025 Jul 1.
3
Beta-Blockers for Secondary Prevention following Myocardial Infarction in Patients Without Reduced Ejection Fraction or Heart Failure: An Updated Meta-Analysis.射血分数未降低或无心力衰竭的心肌梗死患者二级预防用β受体阻滞剂:一项更新的荟萃分析。
Eur J Prev Cardiol. 2024 Sep 20. doi: 10.1093/eurjpc/zwae298.
4
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.急性冠状动脉综合征后左心室射血分数正常或轻度降低时停用β受体阻滞剂的安全性:来自真实世界队列的目标试验模拟
Eur J Prev Cardiol. 2024 Oct 26. doi: 10.1093/eurjpc/zwae346.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
8
Treatment patterns and trajectories in patients after acute heart failure hospitalization.急性心力衰竭住院患者的治疗模式和轨迹。
ESC Heart Fail. 2024 Apr;11(2):692-701. doi: 10.1002/ehf2.14635. Epub 2023 Dec 14.
9
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
10
Survival after myocardial infarction according to left ventricular function and heart failure symptoms.根据左心室功能和心力衰竭症状评估心肌梗死后的生存率。
ESC Heart Fail. 2025 Aug;12(4):2528-2539. doi: 10.1002/ehf2.15265. Epub 2025 Mar 18.

本文引用的文献

1
Precision Cardiology: Phenotype-targeted Therapies for HFmrEF and HFpEF.精准心脏病学:射血分数保留的心力衰竭(HFpEF)和射血分数中间值的心力衰竭(HFmrEF)的靶向表型治疗
Int J Heart Fail. 2024 Mar 25;6(2):47-55. doi: 10.36628/ijhf.2023.0058. eCollection 2024 Apr.
2
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.心肌梗死后射血分数保留的β受体阻滞剂
N Engl J Med. 2024 Apr 18;390(15):1372-1381. doi: 10.1056/NEJMoa2401479. Epub 2024 Apr 7.
3
Empagliflozin after Acute Myocardial Infarction.恩格列净治疗急性心肌梗死。
N Engl J Med. 2024 Apr 25;390(16):1455-1466. doi: 10.1056/NEJMoa2314051. Epub 2024 Apr 6.
4
Myocardial strain of the left ventricle by speckle tracking echocardiography: From physics to clinical practice.超声斑点追踪技术评估左心室心肌应变:从物理学到临床实践。
Echocardiography. 2024 Jan;41(1):e15753. doi: 10.1111/echo.15753.
5
Acute Response of the Noninfarcted Myocardium and Surrounding Tissue Assessed by T2 Mapping After STEMI.ST 段抬高型心肌梗死患者非梗死心肌及周边组织的 T2 Mapping 急性反应评估
JACC Cardiovasc Imaging. 2024 Jun;17(6):610-621. doi: 10.1016/j.jcmg.2023.11.014. Epub 2024 Jan 24.
6
The global prevalence of myocardial infarction: a systematic review and meta-analysis.全球心肌梗死的患病率:一项系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Apr 22;23(1):206. doi: 10.1186/s12872-023-03231-w.
7
Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction.急性心肌梗死后左心室射血分数轻度降低的患者,β受体阻滞剂或肾素-血管紧张素系统抑制剂的药物治疗与临床结局的相关性。
Medicine (Baltimore). 2022 Oct 21;101(42):e30846. doi: 10.1097/MD.0000000000030846.
8
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.血管紧张素受体-脑啡肽酶抑制剂在急性心肌梗死中的应用。
N Engl J Med. 2021 Nov 11;385(20):1845-1855. doi: 10.1056/NEJMoa2104508.
9
Heart failure with mid-range ejection fraction and the effect of β-blockers after acute myocardial infarction.射血分数中间值的心衰和急性心肌梗死后β受体阻滞剂的作用。
Heart Vessels. 2021 Dec;36(12):1848-1855. doi: 10.1007/s00380-021-01876-1. Epub 2021 May 21.
10
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.心力衰竭的通用定义与分类:美国心力衰竭学会、欧洲心脏病学会心力衰竭协会、日本心力衰竭学会及心力衰竭通用定义写作委员会的报告
J Card Fail. 2021 Mar 1. doi: 10.1016/j.cardfail.2021.01.022.